Boston remains biotech's most influential hub, but the questions facing the region are increasingly global. Recorded live at Fierce Biotech Week in Boston, this panel discussion brings together Uli ...

Insider buying matters in every industry, but it carries a special weight in biotechnology. In most businesses, management has a reasonably clear view of sales trends, margins, customer demand, and ...

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning. By ...

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to block those deals have gotten louder. By relying on China to fuel pipelines, ...

Enacted in December 2025 as part of the FY2026 National Defense Authorization Act (NDAA), the Comprehensive Outbound Investment National Security Act currently covers artificial intelligence, ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...